Showing 3451-3460 of 7016 results for "".
JUPITER Study Shows Statins Help Even If Cholesterol Is Normal
https://reachmd.com/programs/lipid-luminations/jupiter-study-shows-statins-help-even-if-cholesterol-is-normal/3933/According to a new study published in the New England Journal of Medicine, men and women who have normal cholesterol levels but signs of inflammation in the blood vessels (high levels of C-reactive protein) can cut the risk of heart attack or stroke in half. Dr. Paul Ridker, author of the studExamining the Biodegradable Stent
https://reachmd.com/programs/heart-matters/examining-the-biodegradable-stent/3983/Will drug-eluting stents prove safer and more effective without a metal structure? For all their merits, current stent technologies still present a series of drawbacks, including the severe complication of late thrombosis. Biodegradable polymers may hold the key to minimizing this and other concernsUpdating Guidelines for Unstable Angina and NSTEMI
https://reachmd.com/programs/heart-matters/updating-guidelines-for-unstable-angina-and-nstemi/3804/Recent guidelines for unstable angina and non-ST-segment-elevation myocardial infarction (NSTEMI) can be characterized as a progression and fine-tuning of past recommendations, which have contributed to a remarkable decline in the devastating outcomes. Dr. Elliott Antman, professor of medicine at HaDoes ApoB Trump Non-HDL Measurements?
https://reachmd.com/programs/lipid-luminations/does-apob-trump-non-hdl-measurements/3181/Consensus is building around apolipoprotein B (apoB) as the preferred tool for gauging the effectiveness of LDL-lowering therapies. Is it accurate, reproducible and cost-effective? Host Dr. Larry Kaskel welcomes Dr. Allan Sniderman, professor of cardiology at the McGill University Health Centre in MBreaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
https://reachmd.com/programs/cme/breaking-ground-2025-milestones-in-cushing-syndrome-and-looking-forward-to-2026/50059/2025 delivered an expanded approval for Cushing syndrome for one agent, a complete response letter for another, and deeper insights on the prevalence of Cushing syndrome (or hypercortisolism) in people with difficult-to-control metabolic conditions. 2026 promises to be jam packed with further insighDiving into the Details of Upadacitinib for UC and Crohn’s Disease
https://reachmd.com/programs/gi-insights/diving-into-the-details-of-upadacitinib-for-uc-and-crohns-disease/24330/A recent study looked at upadacitinib for patients with moderately to severely active ulcerative colitis and Crohn’s disease.Challenging Common Misconceptions About IgAN
https://reachmd.com/programs/clinicians-roundtable/challenging-common-misconceptions-about-igan/14910/There are a number of misconceptions regarding IgA nephropathy. Here’s how we can help clear up the truth.Familial Hypercholesterolemia: Risk Stratifications in Practice
https://reachmd.com/programs/lipid-luminations/familial-hypercholesterolemia-risk-stratifications-in-practice/6479/Who should be tested for genetically elevated cholesterol, or familial hypercholesterolemia? And how do we decide when and how to treat? Host Dr. Alan Brown talks with Dr. Jennifer G. Robinson, director of the Lipid Research Clinic and co-director of the Prevention Intervention Center at the UniverDeciphering Meaningful Use of Health Information Technology
https://reachmd.com/programs/heart-matters/deciphering-meaningful-use-of-health-information-technology/5407/Electronic management of health information will someday replace the pen and paper chart. How significant a role will health information technology, or HIT, play in the newly-reformed healthcare system? What incentives are the federal government offering to foster the widespread, meaningful use of oDo Celebrity Heart Attacks Influence Public Health?
https://reachmd.com/programs/lipid-luminations/do-celebrity-heart-attacks-influence-public-health/3569/Celebrities, often criticized for their dubious influence on the public, may inadvertently promote good health when a famous celebrity dies from a heart attack. Dr. James Erhlich discusses how the sudden death of a famous person heightens the general population’s interest in cardiovascu